This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Immunization  • Alert me on articles by topic  Social Bookmarking   What's this?

Recommendations From the National Vaccine Advisory Committee

National Vaccine Advisory Committee

JAMA. 2003;290:3122-3128.

Between late 2000 and the spring of 2003, the United States experienced shortages of vaccines against 8 of 11 preventable diseases in children. In response, the Department of Health and Human Services requested that the National Vaccine Advisory Committee (NVAC) make recommendations on strengthening the supply of routinely recommended vaccines. The NVAC appointed a Working Group to identify potential causes of vaccine supply shortages, develop strategies to alleviate or prevent shortages, and enlist stakeholders to consider the applicability and feasibility of these strategies. The NVAC concluded that supply disruptions are likely to continue to occur. Strategies to be implemented in the immediate future include expansion of vaccine stockpiles, increased support for regulatory agencies, maintenance and strengthening of liability protections, improved communication among stakeholders, increased availability of public information, and a campaign to emphasize the benefits of vaccination. Strategies requiring further study include evaluation of appropriate financial incentives to manufacturers and streamlining the regulatory process without compromising safety or efficacy.

Authors/National Vaccine Advisory Committee: Georges Peter, MD (chair), Brown Medical School, Providence, RI; Ann Margaret Arvin, MD, Stanford University School of Medicine, Stanford, Calif; Jeffrey P. Davis, MD, Wisconsin Division of Health, Madison, Wis; Michael D. Decker, MD, MPH, Aventis Pasteur, Swiftwater, Pa; Patricia Fast, MD, PhD, International AIDS Vaccine Initiative, New York, NY; Fernando A. Guerra, MD, MPH, San Antonio Metropolitan Health District, San Antonio, Tex; Charles M. Helms, MD, PhD, University of Iowa Hospital and Clinics, Iowa City; Alan Richard Hinman, MD, Task Force for Child Survival and Development, Decatur, Ga; Ruth Katz, JD, MPH, George Washington University School of Public Health and Health Services, Washington, DC; Jerome O. Klein, MD, Boston Medical Center, Boston, Mass; Mary Beth Koslap-Petraco, MS, CPNP, Suffolk County Department of Health Services, Lindenhurst, NY; Peter R. Paradiso, PhD, Wyeth Vaccines, Henrietta, NY; William Schaffner, MD, Vanderbilt University School of Medicine, Nashville, Tenn; Patricia N. Whitley-Williams, MD, Robert Wood Johnson Medical School, New Brunswick, NJ; Donald E. Williamson, MD, Alabama Department of Public Health, Montgomery; and Bruce Gellin, MD, executive secretary of NVAC, Washington, DC.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vaccine Shortages
Red Book 2009;2009:39-39.
FULL TEXT  

Temporary Vaccine Recommendations and Provider Compliance: A Survey of Pediatric Practices During the 2003-2004 Pneumococcal Conjugate Vaccine Shortage
Groom et al.
Pediatrics 2008;122:e835-e840.
ABSTRACT | FULL TEXT  

Pediatricians' Adherence to Pneumococcal Conjugate Vaccine Shortage Recommendations in 2 National Shortages
Fairbrother et al.
Pediatrics 2007;120:e401-e409.
ABSTRACT | FULL TEXT  

Combination Vaccines
Red Book 2006;2006:34a-35a.
FULL TEXT  

Vaccine Shortages
Red Book 2006;2006:39-39.
FULL TEXT  

Who's Calling the Shots? Pediatricians' Adherence to the 2001-2003 Pneumococcal Conjugate Vaccine-Shortage Recommendations
Broder et al.
Pediatrics 2005;115:1479-1487.
ABSTRACT | FULL TEXT  

Immunizations In The United States: Success, Structure, And Stress
Orenstein et al.
Health Aff (Millwood) 2005;24:599-610.
ABSTRACT | FULL TEXT  

The History Of Vaccines And Immunization: Familiar Patterns, New Challenges
Stern and Markel
Health Aff (Millwood) 2005;24:611-621.
ABSTRACT | FULL TEXT  

Why Are Pharmaceutical Companies Gradually Abandoning Vaccines?
Offit
Health Aff (Millwood) 2005;24:622-630.
ABSTRACT | FULL TEXT  

Factors Affecting U.S. Manufacturers' Decisions To Produce Vaccines
Coleman et al.
Health Aff (Millwood) 2005;24:635-642.
ABSTRACT | FULL TEXT  

Future Directions In Vaccines: The Payoffs Of Basic Research
Landry and Heilman
Health Aff (Millwood) 2005;24:758-769.
ABSTRACT | FULL TEXT  

The Fragility of the U.S. Vaccine Supply
Sloan et al.
NEJM 2004;351:2443-2447.
FULL TEXT  

Knowledge, Attitudes, and Beliefs of School Nurses and Personnel and Associations With Nonmedical Immunization Exemptions
Salmon et al.
Pediatrics 2004;113:e552-e559.
ABSTRACT | FULL TEXT